-A modification of the Brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease.

Merat S, Khadem-Sameni F, Nouraie M, Derakhshan MH, Tavangar SM, Mossaffa S, Malekzadeh R, Sotoudeh M.

-Pictogram use was validated for estimating individual's body mass index

Keshtkar AA, Semnani S, Pourshams A, Khademi H, Roshandel G, Boffetta P, Malekzadeh R.

-A survey of the current status of web-based databases indexing Iranian journals.

Merat S, Khatibzadeh S, Mesgarpour B, Malekzadeh R.

Arch Iran Med. 2009 May;12(3):271-8.

 -Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect.

Gholamrezanezhad A, Mirpour S, Ardekani JM, Bagheri M, Alimoghadam K, Yarmand S, Malekzadeh R.

Nucl Med Commun. 2009 Mar;30(3):210-216.

 -A Cross-Sectional Study of Anemia in Human Immunodeficiency Virus-Infected Patients in Iran

Sara Jam MD, Amitis Ramezani MD, Duman Sabzvari MD, Banafsheh Moradmand-Badie MD, SeyedAhmad SeyedAlinaghi MD, Hossain Jabbari MD, Fatemeh Fattahi MD, Minoo Mohraz MD

Archives of Iranian Medicine, Volume 12, Number 2, 2009:145 – 150.

 - Leech endoparasitism: report of a case and review of the literature.

Montazeri F, Bedayat A, Jamali L, Salehian M, Montazeri G.

 Eur J Pediatr. 2009 Jan;168(1):39-42. Epub 2008 Jun 12.

- A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

Rastegarpanah M, Malekzadeh F, Thomas GN, Mohagheghi A, Cheng KK, Marshall T.

Arch Iran Med. 2008 May;11(3):306-13.

 - The upper normal limit of serum alanine aminotransferase in golestan province, northeast iran.

Jamali R, Pourshams A, Amini S, Deyhim MR, Rezvan H, Malekzadeh R.

Arch Iran Med. 2008 Nov;11(6):602-7.

  - Change or perish.

Malekzadeh R, Habibzadeh F.

Arch Iran Med. 2008 Jul;11(4):360. No abstract available.

 - Hemosuccus pancreaticus in a patient with celiac trunk aneurysm.

Fazel I, Asle Soleimani H, Fallah S, Babaei M, Sedighi N, Marashi A, Beniaz F, Malekzadeh R.

Arch Iran Med. 2008 Nov;11(6):658-61.

   - Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis.

Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR.

Dig Dis Sci. 2008 Nov;53(11):3007-11. Epub 2008 May 9.

- Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A.

World J Gastroenterol. 2008 May 14;14(18):2867-71.

- Report from Iran.

Malekzadeh R, Habibzadeh F.

Arch Iran Med. 2008 Jul;11(4):360. No abstract available.

-Transurethral autologous myoblast injection for treatment of urinary incontinence in children with classic bladder exstrophy.

Kajbafzadeh AM, Elmi A, Payabvash S, Salmasi AH, Saeedi P, Mohamadkhani A, Sadeghi Z, Nikfarjam L.

J Urol. 2008 Sep;180(3):1098-105. Epub 2008 Jul 18.

- Halothane hepatitis in Iran: A review of 59 cases.

Eghtesadi-Araghi P, Sohrabpour A, Vahedi H, Saberi-Firoozi M.

World J Gastroenterol. 2008 Sep 14;14(34):5322-6.

 - Antispasmodic effect of hydroalcoholic extract of Thymus vulgaris on the guinea-pig ileum.

Babaei M, Abarghoei ME, Ansari R, Vafaei AA, Taherian AA, Akhavan MM, Toussy G, Mousavi S.

Nat Prod Res. 2008;22(13):1143-50.

 Massarrat S

Arch Iran Med. 2008 May;11(3):293-305.

-The preventive polypill much promise, insufficient evidence.

 Malekzadeh F, Pourshams A, Marshall T

Arch Iran Med. 2007 Jul;10l;10(3)

- Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial.
 Mikaeli J, Bishehsari F, Montazeri G, Mahdavinia M, Yaghoobi M, Darvish-Moghadam S, Farrokhi F, Shirani S, Estakhri A, Malekzadeh R.
 Aliment Pharmacol Ther. 2006 Sep 15; 24(6):983-9.

 Sotoudehmanesh R, Sotoudeh M, Ali-Asgari A, Abedi-Ardakani B, Tavangar SM, Khakinejad A, Sadeghi Z, Malekzadeh R.

Arch Iran Med. 2006 Oct; 9(4):324-8.2.

- "Systematic review": is it different from the "traditional review"?

-Achalasia: a review of Western and Iranian experiences.

Mikaeli J, Islami F, Malekzadeh R.

World J Gastroenterol. 2009 Oct 28;15(40):5000-9.

-Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia.
Montazeri G, Nouri N, Estakhri A, Shirani S, Abedian S, Fazlollahi A, Mikaeli J, Nouraie M, Malekzadeh R.
Eur J Gastroenterol Hepatol. 2006 Nov; 18(11):1203-8.

-Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial.
Mikaeli J, Bishehsari F, Montazeri G, Mahdavinia M, Yaghoobi M, Darvish-Moghadam S, Farrokhi F, Shirani S, Estakhri A, Malekzadeh R.
Aliment Pharmacol Ther. 2006 Sep 15; 24(6):983-9.

- Gender effect on clinical features of achalasia: a prospective study.
Mikaeli J, Farrokhi F, Bishehsari F, Mahdavinia M, Malekzadeh R.
BMC Gastroenterol. 2006 Apr 1; 6:12.

- Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia.
Montazeri G, Nouri N, Estakhri A, Shirani S, Derakhshan MH, Yaghoobi M, Mikaeli J, Malekzadeh R.
Aliment Pharmacol Ther. 2005 Aug 1; 22(3):261-5.

- Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters.
Mikaeli J, Bishehsari F, Montazeri G, Yaghoobi M, Malekzadeh R.
Aliment Pharmacol Ther. 2004 Aug 15; 20(4):431-6.

- Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia.
Mikaeli J, Yaghoobi M, Montazeri G, Ansari R, Bishehsari F, Malekzadeh R.
Dis Esophagus. 2004; 17(3):213-7.

- Correlation between clinical severity score and the lower esophageal sphincter relaxation pressure in idiopathic achalasia.
Yaghoobi M, Mikaeli J, Montazeri G, Nouri N, Sohrabi MR, Malekzadeh R.
Am J Gastroenterol. 2003 Feb; 98(2):278-83.

- Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia.
Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R.
Aliment Pharmacol Ther. 2001 Sep; 15(9):1389-96.

 -Epidemiology of Uninvestigated Gastrointestinal Symptoms in Adolescents: A Population-based Study Applying the Rome II Questionnaire.

Sohrabi S, Nouraie M, Khademi H, Baghizadeh S, Nasseri-Moghaddam S, Malekzadeh R.

J Pediatr Gastroenterol Nutr. 2010 Jun 9

-Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation.

Ansari R, Sohrabi S, Ghanaie O, Amjadi H, Merat S, Vahedi H, Khatibian M.

Indian J Gastroenterol. 2010 Mar;29(2):66-8. Epub 2010 May 5.

A case-control study on risk factors of osteoporosisin patients with Crohn's disease.

Vahedi H, Momtahen S, Olfati G, Abtahi A, Hosseini S, Kazzazi AS, Khademi H, Rashtak S, Khaleghnejad R, Tabrizian T, Hamidi Z, Nouraie M, Malekzadeh F, Merat S, Nasseri-Moghaddam S, Sotoudehmanesh R, Larijani B.

- Crohn's disease and early exposure to domestic refrigeration.

Malekzadeh F, Alberti C, Nouraei M, Vahedi H, Zaccaria I, Meinzer U, Nasseri-Moghaddam S, Sotoudehmanesh R, Momenzadeh S, Khaleghnejad R, Rashtak S, Olfati G, Malekzadeh R, Hugot JP.

PLoS ONE. 2009;4(1):e4288. Epub 2009 Jan 29.

- Morning report: a survey of Iranian senior faculty attitudes.

Rahnavardi M, Bikdeli B, Vahedi H, Alaei F, Pourmalek F, Amini A, Rahnavardi A.

Intern Emerg Med. 2008 Mar;3(1):17-24. Epub 2008 Feb 7.

 - Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?: authors' reply.

Vahedi H, Merat S.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):372-3. No abstract available.

- Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.

 Moravvej H, Razavi GM, Farshchian M, Malekzadeh R.

Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):607-10.

-Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.

Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R

Aliment Pharmacol Ther. 2008 Apr;27(8):678-84. Epub 2008 Jan 30

-Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.

 nsari R, Attari F, Razjouyan H, Etemadi A, Amjadi H, Merat S, Malekzadeh R.

Eur J Gastroenterol Hepatol. 2008 Jan;20(1):46-50. 

-Irritable Bowel Syndrome and Psychiatric Disorders among University Freshmen.
Pourshams A, Zendehdel N, Semnani M, Semnani Y.
Govaresh journal, Volume 11, Number 1, Spring 2006, 22-26.

- The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study.
Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R.
Aliment Pharmacol Ther. 2005 Sep 1; 22(5):381-5.

- Herpes simplex virus encephalistis during immunosuppressive treatment of ulcerative colitis.
Alimohamadi SM, Malekzadeh R, Mirmadjless SH, Mohamadnejad M, Zamani F.
MedGenMed. 2004 Nov 10; 6(4):7. No abstract available.

-The Prevalence of Irritable Bowel Syndrome and Gastroesophageal Reflux Disease Among Tehran.

Mahmudi S, Pourshams A, Akbari M, Malekzadeh R.
Govaresh Journal, Volume 8, Number. 4,winter 2003, 159-62.

 Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms.

Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R.

- Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran.

Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR, Maghsudlu M, Zaer-Rezaii H, Amini S, Siavoshi F, Malekzadeh R.

Helicobacter. 2009 Feb;14(1):40-6.

- Epidemiological study of Gastro-esophageal reflux disease (GERD): GERD in spouse as a risk factor.

Nasseri-Moghaddam S, Mofid A, Ghotbi MH, Razjouyan H, Nouraie M, Zaer-Rezaie H, Habibi R, Rafat-Zand K, Malekzadeh R.

Aliment Pharmacol Ther. 2008 Apr 11. [Epub ahead of print] 

- The normal range of duodenal intraepithelial lymphocytes.

Nasseri-Moghaddam S, Mofid A, Nouraie M, Abedi B, Pourshams A, Malekzadeh R, Sotoudeh M.

Arch Iran Med. 2008 Apr;11(2):136-42.

- Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Tabriz, Iran

MH Somi , S Farhang , S Nasseri-Moghaddam , ESJazayeri, SK Mirinezhad , SM Godrati , M Golchin

Iranian J Publ Health, Vol. 37, No.3, 2008, pp.85-90 Original Article

 -Reliability, Validity, and Feasibility of the Mayo Gastro-Esophageal Reflux Questionnaire (GERQ) in a Persian-Speaking Population

S Nasseri-Moghaddam, H Razjouyan, R Habibi , K Rafaat-Zand, B Ahrari , M Nouraie, R Majdzadeh , H Vahedi, R Malekzadeh

Iranian J Publ Health, Vol. 37, No.2, 2008, pp.64-74 Original Article

-Inter-and intra-observer variability of the Los Angeles classification: a reassessment.

Nasseri-Moghaddam S, Razjouyan H, Nouraei M, Alimohammadi M, Mamarabadi M, Vahedi H, Pourshams A, Mohamadnejad M, Zamani F, Sadr F, Darvish-Moghaddam S, Farsi P, Malekzadeh R.

Arch Iran Med. 2007 Jan;10(1):48-53. Erratum in: Arch Iran Med. 2007 Jul;10(3):429.

-Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey.

Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S.

Arch Iran Med. 2007 Jul;10(3):289-94.

-Hygiene could affect GERD prevalence independently: a population-based study in Tehran.

Nouraie M, Radmard AR, Zaer-Rezaii H, Razjouyan H, Nasseri-Moghaddam S, Malekzadeh R.

Am J Gastroenterol. 2007 Jul;102(7):1353-60. Epub 2007 Apr 16.

-Prospective Acid Reflux Study of Iran (PARSI): methodology and study design.

Nasseri-Moghaddam S, Razjouyan H, Alimohamadi SM, Mamarabadi M, Ghotbi MH, Mostajabi P, Sohrabpour AA, Sotoudeh M, Abedi B, Mofid A, Nouraie M, Tofangchiha S, Malekzadeh R.

BMC Gastroenterol. 2007 Nov 20;7:42.

- Prevalence and precipitating factors of gastroesophageal reflux disease in a young population of Tabriz, Northwest of Iran.
Somi MH, Farhang S, Mirinezhad K, Jazayeri E, Nasseri-Moghaddam S, Moayeri S, Yasrebinia S.
Saudi Med J. 2006 Dec;27(12):1878-81

-Assessment of Inter-and Intra-Observer Variability of the LA Classification for GERD.
Nasseri-Moghaddam S, Malekzadeh R, Razjouyan H, Nouraei SM, Alimohammadi SM, Mamarabadi M, Vahedi H, Pourshams A, Mohamadnejad M,Zamani F,Sadr F, Darvish-MoghaddamS, Farsi P.

Govaresh journal, Volume 11, Number 1, Spring 2006, 27-32

- Gastroesophageal Reflux Disease in Iran.
Pourshams A, Rahmani AR, Hatami K.
Govaresh journal, Volume 10, Number 1, spring 2005, 17-20

-Gastroesophageal Reflux Disease: The New Epidemic.

 R. Malekzadeh, S. Nasseri-Moghaddam, M. Sotoudeh
Arch Iranian Med 2003; 6 (2): 127– 140

 - Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children.

Siavoshi F, Safari F, Doratotaj D, Khatami GR, Fallahi GH, Mirnaseri MM.
Arch Iran Med. 2006 Oct;9(4):308-14.

-Colonoscopic Finding in Children with Lower Gastrointestinal Complaints.
Gholam Reza Khatami, Seyed Mohamad Mahdi Mir-Nasseri, Bahar Allah-Verdi, Fariba Seyghali.
Govaresh journal/ Vol. 10, No. 4, Winter 2005; 233-237.

- Effect of Oral Garlic on Arterial Oxygen Pressure in Children with Hepatopulmonary Syndrome.
Najafi Sani M, Kianifar HR, Kianee A, Khodadad A, khatami GR.
Govaresh journal Volume 10, Number 4, Winter 2005, 199-203.

- "Case Report" Hepatitis-Associated Aplastic Anemia.
Farahmand F, Falahi GH, Shahraki T, Khatami GR, Izadiar M, Ramiar A.
Govaresh journal, Volume 10, Number 1, Spring 2005.

- Autoimmune Hepatitis in Children, Clinical Features and Biochemical of Iranian Children.
Najafi M, Kianifar HR, Mir-Nasseri MM, Khodadad A.
Govaresh journal, Volume 10, Number 2, Summer 2005.

 Long-term follow-up of common bile duct diameter after endoscopic sphincterotomy in patients with common bile duct stones.

Kolahdoozan S, Sotoudehmanesh R, Khatibian M, Ali-Asgari A, Shahraeeni S, Zeinali F.

- Needle-knife if fistulotomy versus standard method for cannulation of common bile duct: a randomized controlled trial.

Khatibian M, Sotoudehmanesh R, Ali-Asgari A, Movahedi Z, Kolahdoozan S.

Arch Iran Med. 2008 Jan;11(1):16-20.

-Role of endoscopic ultrasonography in prevention of unnecessary endoscopic retrograde cholangiopancreatography: a prospective study of 150 patients

Sotoudehmanesh R, Kolahdoozan S, Asgari AA, Dooghaei-Moghaddam M, Ainechi S.

J Ultrasound Med. 2007 Apr;26(4):455. 

-Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.

Sotoudehmanesh R, Khatibian M, Kolahdoozan S, Ainechi S, Malboosbaf R, Nouraie M.

 Am J Gastroenterol. 2007 May;102(5)

-Endoscopic ultrasonography (EUS) in the localization of insulinoma.

Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S.

Endocrine. 2007 Jun;31(3):

-Photoclinic. Ileal duplication cyst.

Hosseini V, Nasseri-Moghaddam S, Soroosh AR, Hakimian MR.

Arch Iran Med. 2007 Jul;n Med. 2007 Jul;10(3):

-Endoscopic lesions in low-to average-risk patients with minimal bright red bleeding from midline anal fissures. How much should we go in?

Sotoudehmanesh R, Ainechi S, Asgari AA, Kolahdoozan S.

Tech Coloproctol. 2007 Dec;11(4):

- Prospective evaluation of endoscopic ultrasonography in the diagnosis of biliary microlithiasis in patients with normal transabdominal ultrasonography .
Mirbagheri SA, Mohamadnejad M, Nasiri J, Vahid AA, Ghadimi R, Malekzadeh R.
J Gastrointest Surg. 2005 Sep-Oct; 9(7):961-4.

- Prospective Evaluation of Endosonography in the Diagnosis of Biliary Microlithiasis in Patients with Normal Transabdominal Ultrasonography
Mirbagheri SA, Mohamadnejad M, Nasiri J, Bagheri M, Atef Vahid A, Ghadimi R, Malekzadeh R.
Govaresh journal Volume 10, Number 1, Spring 2005, 11-16.

- Images in medicine. Cystic duct stump stone.
Mirbagheri SA, Mohamadnejad M, Malekzadeh R.
Hosp Med. 2004 Apr; 65(4):249. No abstract availabl

 -Induction of cytotoxic T lymphocytes primed with Tumor RNA-loaded Dendritic Cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.

Gholamin M, Moaven O, Farshchian M, Mahmoudi M, Sankian M, Memar B, Forghani MN, Malekzadeh R, Rajabi-Mashhadi MT, Abbaszadegan MR.

BMC Cancer. 2010 Jun 7;10(1):261

-Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma.

Moaven O, Raziee HR, Sima HR, Ganji A, Malekzadeh R, A'rabi A, Abdollahi A, Memar B, Sotoudeh M, Naseh H, Nekoui N, Razavipour A, Gholamin M, Dadkhah E, Farshchian M, Abbaszadegan MR.

-p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in Esophageal Squamous Cell Carcinoma.

Taghavi N, Biramijamal F, Sotoudeh M, Khademi H, Malekzadeh R, Moaven O, Memar B, A'rabi A, Abbaszadegan MR.

BMC Cancer. 2010 Apr 13;10:138.

-Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran.

Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R.

Genet Mol Res. 2010 Feb 9;9(1):239-49.

-Five common cancers in Iran.

Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H.

Gholamin M, Moaven O, Memar B, Farshchian M, Naseh H, Malekzadeh R, Sotoudeh M, Rajabi-Mashhadi MT, Forghani MN, Farrokhi F, Abbaszadegan MR.

World J Surg. 2009 May 14. [Epub ahead of print]

  - Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area.

 Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, Merat S, Nasseri-Moghaddam S, Semnani S, Sepehr A, Wakefield J, Møller H, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R.

Int J Epidemiol. 2009 May 4. [Epub ahead of print]

-Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.

Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, Jafari E, Rakhshani N, Salahi R, Semnani S, Kamangar F, Abnet CC, Ponder B, Day N, Dawsey SM, Boffetta P, Malekzadeh R.

Int J Epidemiol. 2009 Mar 30. [Epub ahead of print]

No abstract available.

- Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study.

Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Møller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P.

BMJ. 2009 Mar 26;338:b929. doi: 10.1136/bmj.b929.

 - Epidemiology and Molecular Genetics of Colorectal Cancer in Iran: A Review

 Reza Malekzadeh MD, Faraz Bishehsari MD PhD, Mahboobeh Mahdavinia MD PhD, Reza Ansari MD.

- Reply: Hookah, opium, and tobacco smoking in relation to ESCC.

Malekzadeh R, Nasrollahzadeh D, Kamangar F.

Br J Cancer. 2009 Mar 3. [Epub ahead of print] No abstract available

-Cancer incidence in tehran metropolis: the first report from the tehran population-based cancer registry, 1998 - 2001.

Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M.

Arch Iran Med. 2009 Jan;12(1):15-23.

-Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.

Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M.

BMC Cancer. 2009 Jan 17;9:24.

-Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma.

 Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh R, Dawsey SM.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3062-8.

-Reducing gastric cancer mortality in developing countries: learning from the experience in Japan.

Malekzadeh R, Nasseri-Moghaddam S.

Arch Iran Med. 2008 Sep;11(5):588-90. No abstract available.

 - P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.

Mahdavinia M, Bishehsari F, Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, Ansari R, Semeraro D, Hormazdi M, Fakheri H, Rakhshani N, De Lellis L, Curia MC, Cama A, Piantelli M, Malekzadeh R, Iacobelli S, Mariani-Costantini R.

J Cell Physiol. 2008 Aug;216(2):543-50.

- Helicobacter pylori and esophageal cancer risk: a meta-analysis.

 Islami F, Kamangar F.

Cancer Prev Res (Phila Pa). 2008 Oct;1(5):329-38.

- Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis.

Gorouhi F, Islami F, Bahrami H, Kamangar F.

Br J Cancer. 2008 Apr 22;98(8):1443-51. Epub 2008 Mar 4.

 - Cancer registry in iran: a brief overview.

Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M.

Arch Iran Med. 2008 Sep;11(5):577-80.

-Dietary intake of benzo(a)pyrene and risk of esophageal cancer in North of Iran.

Hakami R, Mohtadinia J, Etemadi A, Kamangar F, Nemati M, Pourshams A, Islami F, Nasrollahzadeh D, Saberi-Firoozi M, Birkett N, Boffetta P, Malekzadeh R.

Nutr Cancer. 2008 Mar-Apr;60(2):216-21.

-Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran.

Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M, Khatibian M, Semnani S, Ye W, Boffetta P, Dawsey SM, Malekzadeh R.

Br J Cancer. 2008 May 13. [Epub ahead of print]

-Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.

Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):174-9

-Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer.

Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, Rakhshani N, Didevar R, Sotoudeh M, Zolfeghari AA, McColl KE.

Gut. 2008 Mar;57(3):298-305. Epub 2007 Oct 26.

-Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.

Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, Zandvakili I, Shakeri R, Sotoudeh M, Aghcheli K, Salahi R, Pourshams A, Semnani S, Boffetta P, Dawsey SM, Ghadirian P, Narod SA.

Oncogene. 2008 Feb 21;27(9):1290-6. Epub 2007 Aug 27.

-Esophageal cancer in Northeastern Iran: a review.

Kamangar F, Malekzadeh R, Dawsey SM, Saidi F.

Arch Iran Med. 2007 Jan;10(1):70-82. Review.

-Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran.

Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R.

Arch Iran Med. 2007 Jan;10(1):32-7.

-Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases.

Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, Semnani S, Eslami F, Marjani HA, Fahimi S, Khademi H, Malekzadeh R.

World J Gastroenterol. 2007 Oct 28;13(40):5367-70. 

-Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer.

Ashktorab H, Daremipouran M, Wilson M, Siddiqi S, Lee EL, Rakhshani N, Malekzadeh R, Johnson AC, Hewitt SM, Smoot DT.

Am J Gastroenterol. 2007 Oct;102(10):2135-46. Epub 2007 Jul 7.

-Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin.
Bishehsari F, Mahdavinia M, Malekzadeh R, Verginelli F, Catalano T, Sotoudeh M, Bazan V, Agnese V, Esposito DL, De Lellis L, Semeraro D, Colucci G, Hormazdi M, Rakhshani N, Cama A, Piantelli M, Iacobelli S, Russo A, Mariani-Costantini R.
Ann Oncol. 2006 Jun; 17 Suppl 7:vii91-vii96.

-Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.
Jazii FR, Najafi Z, Malekzadeh R, Conrads TP, Ziaee AA, Abnet C, Yazdznbod M, Karkhane AA, Salekdeh GH.
World J Gastroenterol. 2006 Nov 28; 12(44):7104-12.

-Esophageal and cardia cancers summit: report of the first meeting.
Nasseri-Moghaddam S, Malekzadeh R.
Arch Iran Med. 2006 Oct; 9(4):442-9. No abstract available.

-Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran.
Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, Sotoudeh M, Semnani S, Boffeta P, Dawsey SM, Ghadirian P, Narod SA.
Int J Cancer. 2006 Sep 1; 119(5):1047-51.

-Endocrine cancer in Iran: based on cancer registry system.
Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, Larijani B.
Indian J Cancer. 2006 Apr-Jun; 43(2):80-5.

- Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada.
Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, Malekzadeh R.
Asian Pac J Cancer Prev. 2006 Jan-Mar; 7(1):86-90.

-Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance.
Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, Fakheri H, Saadatnia H, Ghavamnasiri MR, Malekzadeh R.
Cancer Detect Prev. 2006; 30(1):14-9. Epub 2006 Feb 21.

-Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer.
Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, Hoshiarrad A, Sadatsafavi M, Golestan B, Yoonesi A, Rakhshani N, Fahimi S, Nasrollahzadeh D, Salahi R, Ghafarpour A, Semnani S, Steghens JP, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R.
Eur J Clin Nutr. 2006 Aug; 60(8):971-7. Epub 2006 Feb 8.

-Esophageal cancer in northeastern Iran.
Semnani SH, Besharat S, Abdolahi N, Kalavi KH, Fazeli SA, Davarian A, Danesh A, Malekzadeh R.
Indian J Gastroenterol. 2005 Sep-Oct; 24(5):224. No abstract available.

-Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population.
Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R.
World J Gastroenterol. 2005 Feb 28; 11(8):1200-3.

-Changing epidemiology of IPSID in Southern Iran.
Lankarani KB, Masoompour SM, Masoompour MB, Malekzadeh R, Tabei SZ, Haghshenas M.
Gut. 2005 Feb; 54(2):311-2. No abstract available.

-Golestan cohort study of oesophageal cancer: feasibility and first results.
Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, Yoonessi A, Semnani S, Islami F, Sotoudeh M, Fahimi S, Sadjadi AR, Nasrollahzadeh D, Aghcheli K, Kamangar F, Abnet CC, Saidi F, Sewram V, Strickland PT, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R.
Br J Cancer. 2005 Jan 17; 92(1):176-81.

-High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran.
Kamangar F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, Abnet CC, Saadatian-Elahi M, Rakhshani N, Brennan P, Etemadi A, Dawsey SM.
Anticancer Res. 2005 Jan-Feb; 25(1B):425-8.

S. Massarrat
Arch Iranian Oct2005,Volume 8, Number 4.

-Family history of colorectal cancer in Iran.
Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, Rakhshani N, Malekzadeh R.
BMC Cancer. 2005 Sep 5; 5:112.

-Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry.
Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, Fakheri H, Semnani S, Arshi S, Zahedi MJ, Darvish-Moghadam S, Mansour-Ghanaei F, Mosavi A, Malekzadeh R.
Cancer Lett. 2006 Aug 18; 240(1):143-7. Epub 2005 Nov 8.

- Hereditary risk factors for the development of gastric cancer in younger patients.
Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, Mohammadkhani A, Attari A, Akbari MR, Hormazdi M, Malekzadeh R.
BMC Gastroenterol. 2004 Oct 27; 4:28.

-Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran.
Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, Taylor PR, Kamangar F, Dawsey SM, Malekzadeh R.
Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1068-70.

-Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison.
Sepehr A, Kamangar F, Abnet CC, Fahimi S, Pourshams A, Poustchi H, Zeinali S, Sotoudeh M, Islami F, Nasrollahzadeh D, Malekzadeh R, Taylor PR, Dawsey SM.
Cancer Lett. 2004 Sep 30; 213(2):195-202.

- Ecologic study of serum selenium and upper gastrointestinal cancers in Iran.
Nouarie M, Pourshams A, Kamangar F, Sotoudeh M, Derakhshan MH, Akbari MR, Fakheri H, Zahedi MJ, Caldwell K, Abnet CC, Taylor PR, Malekzadeh R, Dawsey SM.
World J Gastroenterol. 2004 Sep 1; 10(17):2544-6.

-Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran.
Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, Marjani HA, Merat S, Nasseri-Moghaddam S, Pourshams A, Nouraie M, Khatibian M, Abedi B, Brazandeh MH, Ghaziani R, Sotoudeh M, Dawsey SM, Abnet CC, Taylor PR, Malekzadeh R.
Br J Cancer. 2004 Apr 5; 90(7):1402-6.

- Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran .
Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, Yoonessi A, Tavangar M, Abedi BA, Sotoudehmanesh R, Pourshams A, Asgari AA, Doulatshahi S, Alizadeh BZ, Arshi S, Madjidpoor A, Mir Moomen S, Fleischer DE.
J Clin Pathol. 2004 Jan; 57(1):37-42.

-High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran.
Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, Malekzadeh R.
Gut. 2004 Sep; 53(9):1262-6.

-Adenocarcinoma of the colon associated with sarcoidosis.
Mohamadnejad M, Babai M, Bidari A, Malekzadeh R, Tavangar SM.
MedGenMed. 2003 Mar 3; 5(1):6.

-Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran.
Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, Mosavi A, Mohagheghi MA, Alimohammadian M.
Int J Cancer. 2003 Oct 20; 107(1):113-8. Erratum in: Int J Cancer. Note: 2003 Dec 20; 107(6):1059.

-Endoscopic esophageal cancer survey in the western part of the Caspian Littoral.
Saidi F, Malekzadeh R, Sotoudeh M, Derakhshan MH, Farahvash MJ, Yazdanbod A, Merat Sh, Mikaeli J, Sotoudehmanesh R, Nasseri-Moghadam S, Majidpour A, Arshi S, Abedi-Ardakani B, Yoonessi A, Sadr F, Sepehr A, Fleischer D, Fahimi S.
Dis Esophagus. 2002; 15(3):214-8.

 -Ethnic and geographic differentiation of Helicobacter pylori within Iran.

Latifi-Navid S, Ghorashi SA, Siavoshi F, Linz B, Massarrat S, Khegay T, Salmanian AH, Shayesteh AA, Masoodi M, Ghanadi K, Ganji A, Suerbaum S, Achtman M, Malekzadeh R, Falush D.

PLoS One. 2010 Mar 22;5(3):e9645.

- Production of polyclonal antibody against alkyl hydroperoxide reductase of Helicobacter pylori and its antigenicity.

 Mohammadian T, Doosti M, Paknejad M, Siavoshi F, Massarrat S, Soukhtanloo M.

Hybridoma (Larchmt). 2008 Dec;27(6):481-5.

- H. pylori-induced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria.

 Ashktorab H, Dashwood RH, Dashwood MM, Zaidi SI, Hewitt SM, Green WR, Lee EL, Daremipouran M, Nouraie M, Malekzadeh R, Smoot DT.

Helicobacter. 2008 Dec;13(6):506-17.

- Yeast of the oral cavity is the reservoir of Heliobacter pylori.

 Salmanian AH, Siavoshi F, Akbari F, Afshari A, Malekzadeh R.

J Oral Pathol Med. 2008 Jul;37(6):324-8. Epub 2008 Feb 5.

Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanbod A, Tavangar SM, Mikaeli J, Merat S, Malekzadeh R.

Dig Dis Sci. 2008 Jan;53(1):27-33. Epub 2007 May 10.

-Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.

Foroumadi A, Rineh A, Emami S, Siavoshi F, Massarrat S, Safari F, Rajabalian S, Falahati M, Lotfali E, Shafiee A.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3315-20.Epub2008Apr 15

-Advantage of using a home-made elisa kit for detection of Helicobacter pylori infection over commercially imported kits.

Mohammadi M, Talebkhan Y, Khalili G, Mahboudi F, Massarrat S, Zamaninia L, Oghalaei A.

Indian J Med Microbiol. 2008 Apr-Jun;266(2):127-31

-Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients.

Latifi-Navid S,Siavoshi F,Safari F,Malekzadeh R,Massarrat.S.

J Antimicrob Chemother. 2007 Jan;59(1):160-1. Epub 2006 Nov 3. No abstract available

-Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.

Khatibian M, Ajvadi Y, Nasseri-Moghaddam S, Ebrahimi-Dariani N, Vahedi H, Zendehdel N, Sotoudehmanesh R, Agah S, Mikaeli J, Pourshams A, Ali-Asgari A, Malekzadeh R, Massarrat S.

Arch Iran Med. 2007 Apr;10(2):161-7.

- Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients.
Latifi-Navid S, Siavoshi F, Safari F, Malekzadeh R, Massarrat S.
J Antimicrob Chemother. 2006 Nov 3; [Epub ahead of print] No abstract available.

-Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.
Safaralizadeh R, Siavoshi F, Malekzadeh R, Akbari MR, Derakhshan MH, Sohrabi MR, Massarrat S.
East Mediterr Health J. 2006 May-Jul; 12(3-4):286-93.

- Helicobacter pylori endemic and gastric disease.
Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H.
Dig Dis Sci. 2005 Nov; 50(11):2075-80.

-Detection of Helicobacter pylori-specific genes in the oral yeast.
Siavoshi F, Salmanian AH, Akbari F, Malekzadeh R, Massarrat S.
Helicobacter. 2005 Aug; 10(4):318-22. Erratum in: Helicobacter. 2005 Oct; 10(5):557.

-Helicobacter pylori reinfection rate 3 years after successful eradication.
Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M, Siavoshi F.
J Gastroenterol Hepatol. 2005 Mar; 20(3):401-4.

-Association between Helicobacter pylori Infection in gastric cancer, ulcers and gastritis in Iranian patients.
Siavoshi F, Malekzadeh R, Daneshmand M, Smoot DT,Ashktorab H.
Helicobacter. 2004 Oct; 9(5):470. No abstract available.

-DNA Fingerprinting of H. Pylori Isolates from Iranian Patients by REP-PCR.
Siavoshi F, Zabihinia S, Malekzadeh R, Dinparast Jadid N, Massarrat S, Omrani A.
Govaresh journal, Volume 9, Number 2, Summer 2004, 81-89.

-Neutralization of Helicobacter Pylori Cytotoxicity on Vero Cells by Omeprazole.
Latifi Navid S, Siavoshi F, Mokhtari Azad T, Malekzadeh R, Sohrabi MR, Massarrat S.
Govaresh journal, Volume 9, Number 3, Autumn 2004, 161-168.

-Genotype Variation in H. Pylori Isolates from Iranian Patients by RAPD-PCR.
Siavoshi F, Shokouhfard M, Malekzadeh R, Dinparast Jadid N, Massarrat S, Emrani A.
Govaresh journal, Vol. 9 \ No. 1 \ Spring 2004, 18-21

-Treatment of Helicobacter pylori Infection in Iran: Low Efficacy of Recommended Western Regimens.

 R. Malekzadeh, M. Mohamadnejad, F. Siavoshi, S. Massarrat
Arch Iran Med 2004, Volume 7, Number 1.

-Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.
Fakheri H, Merat S, Hosseini V, Malekzadeh R.
Aliment Pharmacol Ther. 2004 Jan 1; 19(1):89-93.

-Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.
Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotoudemanesh R, Sotoudeh M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arshi S, Majidpour A.
J Gastroenterol Hepatol. 2003 Jan; 18(1):13-7.

-Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.
Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S; Iranian Functional Dyspepsia Study Group.
Digestion. 2002; 66(2):92-8.

-Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, Massarrat S.
Eur J Gastroenterol Hepatol. 2001 Aug; 13(8):915-9.

-Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Fakheri H, Malekzadeh R, Merat S, Khatibian M, Fazel A, Alizadeh BZ, Massarrat S.
Aliment Pharmacol Ther. 2001 Mar; 15(3):411-6.

-A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
Sotudehmanesh R, Malekzadeh R, Fazel A, Massarrat S, Ziad-Alizadeh B, Eshraghian MR.
J Gastroenterol Hepatol. 2001 Mar; 16(3):264-8.

-Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Sotoudehmanesh R, Malekzadeh R, Vahedi H, Dariani NE, Asgari AA, Massarrat S.
Digestion. 2001; 64(4):222-5.

 R. Malekzadeh
Arch Irn Med 2001; 4 (4): 212-213

-Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.
Malekzadeh R, Ansari R, Vahedi H, Siavoshi F, Alizadeh BZ, Eshraghian MR, Vakili A, Saghari M, Massarrat S.
Aliment Pharmacol Ther. 2000 Mar; 14(3):299-303.

-Susceptibility of Various Strains of Helicobacter pylori to Selected Agents.

F.Siavoshi PhD,A.H.Pourkhajeh MD,S.Merat MD, H.Asl-Soleimani MD, E. Heydarian,M.Khatibian MD,R.Malekzadeh MD.
Arch Irn Med Apr. 2000, Volume 3, Number 2

-Prevalence of Helicobacter Pylori in Two Iranian Provinces with High and Low Incidence of Gastric Carcinoma.

J. Mikaeli MD, R. Malekzadeh MD, B. Ziad Alizadeh MD, S. Nasseri Mogaddam MD, M.Valizadeh MD, R. Khoncheh MD,S.Massarrat MD.
Arch Irn Med Jan. 2000, Volume 3, Number 1

-Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Kashifard M, Malekzadeh R, Siavoshi F, Mikaeli J, Massarrat S.
Eur J Gastroenterol Hepatol. 1998 Oct; 10(10):847-50.

-Ten versus 28 days of cimetidine treatment for duodenal ulcer in Iran. Evidence for the need for risk-oriented individual treatment of ulcer patients.
Malekzadeh R, Ayattallahi MT, Massarrat S.
Hepatogastroenterology. 1991 Aug; 38(4):295-8.

-Psoriasis and Coeliac disease; is there any relationship?

Zamani F, Alizadeh S, Amiri A, Shakeri R, Robati M, Alimohamadi SM, Abdi H, Malekzadeh R.

-Coeliac disease in autoimmune liver disease: A cross-sectional study and a systematic review.

Mirzaagha F, Azali SH, Islami F, Zamani F, Khalilipour E, Khatibian M, Malekzadeh R.

Zamani F, Shahram F, Shakeri R, Zayyeni H, Davatchi F, Amiri A, Malekzadeh R.

Dig Dis Sci. 2009 Aug;54(8):1736-9. Epub 2008 Nov 7.

- Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin.

Zamani F, Mohamadnejad M, Shakeri R, Amiri A, Najafi S, Alimohamadi SM, Tavangar SM, Ghavamzadeh A, Malekzadeh R.

 World J Gastroenterol. 2008 Dec 28;14(48):7381-5.

 -Prevalence of gluten-sensitive enteropathy and coeliac disease in Iran

Malekzadeh R, Akbari MR.

Eur J Gastroenterol Hepatol. 2007 Sep;19(9):825-6. No abstract available.

- Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
Reza Akbari M, Mohammadkhani A, Fakheri H, Javad Zahedi M, Shahbazkhani B, Nouraie M, Sotoudeh M, Shakeri R,Malekzadeh R.
Eur J Gastroenterol Hepatol. 2006 Nov; 18(11):1181-6.

- Coeliac disease in developing countries: Middle East, India and North Africa.
Malekzadeh R, Sachdev A, Fahid Ali A.
Best Pract Res Clin Gastroenterol. 2005 Jun; 19(3):351-8. Review.

- Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder?
Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C.
Dig Liver Dis. 2004 Oct; 36(10):694-7.

- Coeliac disease is the most common cause of chronic diarrhoea in Iran.
Shahbazkhani B, Mohamadnejad M, Malekzadeh R, Akbari MR, Esfahani MM, Nasseri-Moghaddam S, Sotoudeh M, Elahyfar A.
Eur J Gastroenterol Hepatol. 2004 Jul; 16(7):665-8.

- Coeliac disease in Iranian type I diabetic patients.
Shahbazkhani B, Faezi T, Akbari MR, Mohamadnejad M, Sotoudeh M, Rajab A, Tahaghoghi S, Malekzadeh R.
Dig Liver Dis. 2004 Mar; 36(3):191-4.

- Microenteropathy; the entity of the new millennium. Overview of the second asian symposium on coeliac disease, October 18-21, 2003, Tehran.
Rostami K, Shahbazkhani B, Malekzadeh R.
Rom J Gastroenterol. 2004 Mar; 13(1):29-31. No abstract available.

- Coeliac disease presenting with symptoms of irritable bowel syndrome.
Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, Malekzadeh R.
Aliment Pharmacol Ther. 2003 Jul 15; 18(2):231-5.

- High prevalence of coeliac disease in apparently healthy Iranian blood donors.
Shahbazkhani B, Malekzadeh R, Sotoudeh M, Moghadam KF, Farhadi M, Ansari R, Elahyfar A, Rostami K.
Eur J Gastroenterol Hepatol. 2003 May; 15(5):475-8.

Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase.

Montazeri G, Rahban M, Mohamadnejad M, Zamani F, Hooshyar A, Fazlolahi A, Abedian S, Ghoujeghi F, Estakhri A, Montazeri F, Razjoyan H, Mamarabadi M, Alimohamadi M, Tavangar SM, Malekzadeh R.

Arch Iran Med. 2010;13(3):193-202.

-Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S.

Int J Infect Dis. 2010 Mar 31.

-Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load.

Shahzamani K, Merat S, Rezvan H, Mirab-Samiee S, Khademi H, Malekzadeh R, Sabahi F.

Clin Chem Lab Med. 2010 Jun;48(6):777-84.

-Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study.

Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.

Arch Iran Med. 2010;13(2):99-104.

-Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A.

-The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in iran: a population-based study.

Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.

Arch Iran Med. 2009 May;12(3):225-31.

-Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.

Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R.

J Viral Hepat. 2008 Oct;15(10):753-60. Epub 2008 May 27.

- Interferon resistance of hepatitis C virus genotypes 1a/1b: relationship to structural E2 gene quasispecies mutations

 Maryam Honardoost, Farzaneh Sabahi, Samad Amini-Bavil-Olyaee, Farida Behzadian, Shahin Merat, Reza Malekzadeh

Iranian Journal of Biotechnology (IJB), Vol 6, No 1, (2008)

 -Hepatitis C seroprevalence among intravenous drug users in Tehran

Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.

J Hepatol. 2008 Jan;48(1):28-34. Epub 2007 Oct 1.

 -A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency.

Montazeri F, Montazeri G, Bedayat A, Sedighi N.

Ann Hematol. 2008 Apr;87(4):333-5. Epub 2007 Oct 17. No abstract available

 -Persistent alanine aminotransferase elevation among the general Iranian population: Prevalence and causes.

Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A.

World J Gastroenterol. 2008 May 14;14(18):2867-71.

-Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis.

Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H.

World J Gastroenterol. 2007 Jun 28;133(24):3359-63.

-Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up.

Fazel I, Pourshams A, Merat S, Hemayati R, Sotoudeh M, Malekzadeh R.

J Gastrointest Surg. 2007 Aug;111(8):1033-8.

-Stem cell therapy in Iran.

Massarrat S.

Arch Iran Med. 2007 Oct;10(4):435-8. No abstract available.

-Phase 1 trial of rial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R.

Arch Iran Med. 2007 Oct;100(4):459-66.

- Current treatment of chronic hepatitis B.

 Montazeri G.
Arch Iranian Med 2006; 9 (1): 1 – 10.

- Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone.

Kabir A, Alavian SM, Ahanchi N, Malekzadeh R.
Hepatol Res. 2006 Dec; 36(4):265-71. Epub 2006 Sep 11.

- Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R.
Am J Gastroenterol. 2006 Nov; 101(11):2537-45. Epub 2006 Oct 4.

-Hereditary hemochromatosis: a rare disease in Iran.
Nobakht H, Merat S, Malekzadeh R.
Arch Iran Med. 2006 Jan; 9(1):78-80.
Arch Iranian Med 2006; 9 (1): 1 – 10.

-Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
Mohamadnejad M, Malekzadeh R, Nasseri-Moghaddam S, Hagh-Azali S, Rakhshani N, Tavangar SM, Sedaghat M, Alimohamadi SM.
Dig Dis Sci. 2005 Mar; 50(3):547-51.

-Therapeutic efficacy of an angiotensin ii receptor antagonist in patients with Nonalcoholic Steatohepatitis

 S. Merat, R. Malekzadeh.
Arch Iran Med 2005, Volume 8, Number 2.

- Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. BMC Gastroenterol. 2005 Oct 12; 5:32.

- Efficacy of Hepatitis B Virus Surface Antigen Vaccine as a Therapeutic Tool, in Inactive Hepatitis B Virus Carriers.

Montazeri Gh, Farzadi Z, Fazllolahi A, Abedian Sh, Montazeri F, Estakhri A, Noori N, Malekzadeh R.
Govaresh journal / Vol. 10, No. 4, Winter 2005; 227-232.

- A Comparison between Pegylated Interferon Alpha-2a and Standard Interferon in Combination with Ribavirin in Treating Patients with Bleeding Disorders and Chronic Hepatitis C.

Merat Sh, Sohrabpour AA, Khaleghi S, Sohrabi MR, Samimi-Rad K, Radmard AR, Mousavian A, Keyvani H, Rezvan H, Malekzadeh R.
Govaresh journal, Vol. 10, No. 2, Summer 2005; 108-115.

- HCV in Intravenous Drug Users.

Mir-Nasseri MM, Poustchi H, Nasseri-Moghadam S, Nouraie SM, Tahaghoghi S, Afshar P, Mohammadkhani A, Tavakoli H, Malekzadeh R.
Govaresh journal, Volume 10, Number 2, Summer 2005, 80-86.

- Interferon Monotherapy in Major Thalassemic Patients with Hepatitis C Infection.

Farhad Zamani, Ramin Shakeri, Masoomeh Islam, Hassan Taheri, Mehdi Mohamadnejad, Reza Malekzadeh.
Govaresh journal, Vol. 10, No. 3, Autumn 2005; 178-182.

-Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region.

Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L.
J Med Virol. 2004 Oct; 74(2):246-52

- Reversibility of cirrhosis in autoimmune hepatitis.
Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, Rakhshani N, Tavangar SM, Sohrabpour AA, Tahaghoghi S.
Am J Med. 2004 Jul 15; 117(2):125-9. No abstract available.

- Hepatitis B.

Mohamadnejad M, Malekzadeh R.
N Engl J Med. 2004 Jun 24; 350(26):2719-20. No abstract available.

- Reversibility of cirrhosis in chronic hepatitis B.

Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, Tavangar SM, Sohrabpour AA.
Clin Gastroenterol Hepatol. 2004 Apr; 2(4):344-7.

- Hepatitis C in Hemophiliac Patients.

Alavian SM, Hajarizadeh B, Malekzadeh R.
Govaresh journal, Volume 8, Number. 4, Winter 2003.

- Passive and Active Immunization in Prevention of Vertical Transmission of HBV Infection in Infants of HBsAg Positive Mothers.

Malekzadeh R, Alavian SM, Kabir A, Ahanchi N.
Govaresh journal, Volume 9, Number 3, Autumn 2004, 181-187.

-Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors.

Alavian SM, MoMalekzadeh stajabi P, R, Azimi K, Vosough H, Sarrafi M, Daneshfar B, Riyazi Sh,Ahmadzad Asl M.
Govaresh journal, Volume 9, Number 3, Autumn 2004, 169-175.

 M. Mohammadnejad, R. Malekzadeh, S. Rad.
Arch Iran Med 2004, Volume 7, Number 4

- Screening for hepatitis C virus infection: a review of the evidence for the U.S. preventive services task Force. S. Nasseri-Moghaddam, R. Malekzadeh.
Arch Iran Med, April 2004, Volume 7, Number 2

-Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study.
Merat S, Malekzadeh R, Sohrabi MR, Sotoudeh M, Rakhshani N, Sohrabpour AA, Naserimoghadam S.
J Hepatol. 2003 Apr; 38(4):414-8.

-Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study.
Merat S, Malekzadeh R, Sohrabi MR, Hormazdi M, Naserimoghadam S, Mikaeli J, Farahvash MJ, Ansari R, Sotoudehmanesh R, Khatibian M.
J Clin Gastroenterol. 2003 Mar; 36(3):266-8.

- Hepatitis B in Iran

 Meraat Sh, Malekzadeh R, Rezvan H, Khatibian M.
Arch Iran Med Volume 3, Number 4 Oct. 2